Intro + Oncogenes Flashcards
How is cell division controlled?
= TIGHTLY!
Cells normally only divide in response to extracellular signals (growth factors)
Unwanted cells lost through apoptosis, anoikis
Processes (e.g. cell growth / anti-growth, cell death / survival)
= controlled by :
Tumour suppressor genes
Proto-oncogenes
What does loss of control over cell division cause?
Tumour Growth
Mutations that cause loss of tumour suppressor genes / gain of function of protooncogenes
= tip balance towards HYPERPROLIFERATION
What are oncogenes?
A gene whose presence results in a cancerous phenotype
Dominant at cellular genetic level (only need 1 copy)
Derived from genes normally involved in regulating proliferation and survival (proto-oncogenes) through either mutation or misregulation
How were cellular oncogenes identified?
Originally thought to be infectious / viral disease
Transfection Protocol.
- Chemically transformed mouse fibroblasts
- DNA transfection using calcium phosphate co-preciptation procedure (crystals forms)
- Add to Normal mouse fibroblasts (crystals taken up)
- Formation of a focus (cancerous phenotype) of morphologically transformed cells
- Injection of morphologically transformed cells into mouse host
- Xenograph - forms tumour on mouse
= proved genetic origin
What are some of the mechanisms for oncogene activation (from proto-oncogene)?
Deletion / Point mutation in coding sequence
= hyperactive protein made in normal amounts
Regulatory mutation
= normal protein greatly overproduced
Gene Amplification
= normal protein greatly overproduced
Chromosome Rearrangement
= nearby regulatory DNA sequences causes normal protein to be overproduced
OR
= fusion to actively transcribed gene produces hyperactive fusion protein
(Extra Reading)
= can also have Viral integration
- some viruses integrate DNA into host genome and activate proto-oncogenes (e.g. HPV, EBV)
= epigenetic alterations
- e.g. DNA methylation and histone modification
- can lead to activation of proto-oncogenes by altering their expression
What the (7) type of oncogenes?
Can derive from following growth regualtory genes (proto-oncogenes):
- Growth factors
- Growth factor receptors (e.g. Receptor tyrosine kinases)
- G proteins
- Intracellular serine/ threonine kinases
- Intracellular tyrosine kinases
- Transcription factors
- Negative regulators of apoptosis (e.g. Bcl)
Autocrine signalling in cancer? (Growth factors as oncogenes) + examples?
Normal cells = paracrine or endocrine signalling
= cells do NOT produced own growth factors
Cancer cells = autocrine signalling
= produce own growth factor through mutation
= uncontrolled growth
e.g. TGFα
= ligand of epidermal growth factor receptor (EGFR)
= produced by lung, prostate, pancreatic, mesothelioma and breast cancer
Other e.g. (+receptor)
= SCF (Kit)
= VEGF-A (VEGF-R)
= HGF (Met)
= NRG (HER2/HER3)
How does deregulation of receptor firing happen in cancer? (growth factor receptor as oncogenes)
Normal cell
= ligand-dependent firing
= dimerisation = activates kinase activity
Cancer cell
= ligand-independent firing
= through mutations affecting structure or overexpression
= can dimerise without ligand , activating kinase activity
overexpression e.g. = HER2 oncogene and breast cancer
What are G-proteins and example? (G proteins as oncogenes)
= large family of proteins activated by binding GTP
= subfamily - monomerical small GTPases e.g. Ras
= bind GTP = on
= bind GDP = off (in cancer can not turn off)
= activated by GEFs (guanaine nucleotide exchange factors)
= inactivated by GAPs (GTPase activating proteins)
= Ras proteins: HRAS, NRAS, KRAS4A, KRAS4B = encoded by 3 genes
(Extra Reading)
= other examples
- Gαq = cell growth and division = breast, liver, colon
- Gαs = cAMP production and PKA activation = thyroid, adrenal cortical carcinoma
-Gα12/13 = regulate cell shape and motility = gastric cancer, hepatocellular carcinoma
What do adaptor proteins do? (G proteins as oncogenes)
link receptor tyrosine kinase firing to RAS
Examples of Ras mutations in cancer?
KRAS most common
= pancreatic (57%), colorectal (33%), biliary tract (31%), small intestine (20%), lung (17%), ovary (14%), endometrium (14%)
= usually codons 12, 13, 61
NRAS
= skin (18%), haemopoietic (10%), thyroid (8%)
= usually codons 12,13, 61
HRAS
= cervical (9%), head and neck (15%)
= usually codon 12
= activate downstream signalling pathways involved in cell growth and survival
Ras Mutation Hotspots?
= codon 12 most common site of point mutation
= most mutations are gain of function
= mutational hotspots correlate with decreased GTPase activity
= conformational change
G proteins and Intracellular serine / threonine kinases as oncogenes?
Mutant RAS / downstream serine / threonine kinases
= lead to abnormal proliferation
Mutations in downstream components of cascade also occur
= B-raf V600E and V600K mutations seen in melanoma
Intracellular tyrosine kinases as oncogenes? The bcr-abl oncogene?
Translocation between chromosomes 9 and 22
= the Philadelphia chromosome
= and the bcr-abl oncogene
= encodes Bcr-abl fusion protein (= constitutively active tyrosine kinase)
= found in >95% of chronic myelogenous leukaemia (CML)
How does bcr-abl oncogene cause cancer?
There is dimerisation
= transactivation
= becomes permanently switched on
= causes defects in many signalling pathways which drive phenotype of CML (+ small subset of ALL)
= results in proliferation and survival, transcription, proliferation, survival
(hallmarks of cancer)
= e.g. of downstream signalling pathways activated by BCR-ABL
= RAS-MAPK, PI3K-AKT
= also disrupts normal DNA repair mechanisms and increased genomic instability of leukemic cells